MedElevator Войти в исследования
← Поиск публикаций

DOI 10.23736/s2724-6051.23.05342-9

Медицинская библиотека · Minerva urology and nephrology · 2023

Regional differences in stage distribution and rates of treatment for adrenocortical carcinoma across United States SEER registries.

Panunzio Andrea, Tappero Stefano, Piccinelli Mattia, Cano Garcia Cristina, Barletta Francesco, Incesu Reha-Baris, Law Kyle W, Tian Zhe, Tafuri Alessandro, Saad Fred, Shariat Shahrokh F, Tilki Derya, Briganti Alberto, Chun Felix K, DE Cobelli Ottavio, Terrone Carlo, Bourdeau Isabelle, Cerruto Maria A, Antonelli Alessandro, Karakiewicz Pierre I

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

We tested for regional differences across United States (US) in rates of adrenalectomy, systemic therapy, and adrenalectomy and systemic therapy combination for adrenocortical carcinoma (ACC) patients. We hypothesized that no differences exist, especially after accounting for baseline patient and tumor characteristics.

METHODS

Within Surveillance, Epidemiology, and End Results (SEER) database (2004-2018), 1275 ACC patients were identified. Distribution of patient age, tumor size, ENSAT (European Network for the Study of Adrenal Tumors) stages, and treatments were tabulated and graphically displayed, according to nine geographical registries, corresponding to the population of specific states, cities or macro areas of the US on which the data are based on. Multinomial models predicted treatment probability for each patient according to registries.

RESULTS

Patients count according to registries ranged from 62 to 509. Differences across registries existed for age (range 54-59 years; P=0.4), tumor size (8.5-11.0 cm; P=0.2), ENSAT stage (1-11% vs. 17-35% vs. 18-32% vs. 24-44%, in respectively ENSAT stage I, II, III, and IV), and treatment distribution (35-53% vs. 5-21% vs. 23-42%, in respectively adrenalectomy, systemic therapy, and adrenalectomy and systemic therapy combination; P=0.039). After adjustment for age, stage and year of diagnosis, clinically meaningful residual differences across registries remained for adrenalectomy (33-54%), systemic therapy (4-19%), and adrenalectomy and systemic therapy combination (20-38%). However, most variability originated from registries with smallest sample sizes.

CONCLUSIONS

We identified important variability in ACC treatment according to SEER geographical registries, even after considering baseline patient and tumor characteristics. These findings may be indicative of differences in quality of care or expertise in ACC management.

Для цитирования: Panunzio Andrea, Tappero Stefano, Piccinelli Mattia, Cano Garcia Cristina, Barletta Francesco, Incesu Reha-Baris, Law Kyle W, Tian Zhe, Tafuri Alessandro, Saad Fred, Shariat Shahrokh F, Tilki Derya, Briganti Alberto, Chun Felix K, DE Cobelli Ottavio, Terrone Carlo, Bourdeau Isabelle, Cerruto Maria A, Antonelli Alessandro, Karakiewicz Pierre I. Regional differences in stage distribution and rates of treatment for adrenocortical carcinoma across United States SEER registries.. Minerva urology and nephrology. 2023. DOI: 10.23736/s2724-6051.23.05342-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.